Volume 136, Issue 2, Pages e3 (February 2009)

Slides:



Advertisements
Similar presentations
Volume 137, Issue 4, Pages (October 2009)
Advertisements

Volume 44, Issue 2, Pages (February 2006)
Volume 132, Issue 5, Pages (May 2007)
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 140, Issue 2, Pages e1 (February 2011)
Volume 131, Issue 1, Pages (July 2006)
Volume 134, Issue 3, Pages e2 (March 2008)
Volume 137, Issue 4, Pages (October 2009)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Volume 128, Issue 5, Pages (May 2005)
Volume 133, Issue 5, Pages e1 (November 2007)
Volume 154, Issue 3, Pages e8 (February 2018)
Volume 144, Issue 7, Pages e10 (June 2013)
PTF1α/p48 and cell proliferation
Volume 143, Issue 5, Pages e4 (November 2012)
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Stephanos J. Hadziyannis  Journal of Hepatology 
Volume 124, Issue 7, Pages (June 2003)
Volume 124, Issue 5, Pages (May 2003)
Volume 123, Issue 4, Pages (October 2002)
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 142, Issue 5, Pages e6 (May 2012)
Volume 128, Issue 7, Pages (June 2005)
Volume 140, Issue 5, Pages (May 2011)
Volume 130, Issue 2, Pages (February 2006)
Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance  Chao-Wei Hsu, Chau-Ting Yeh, Ming-Ling.
Volume 135, Issue 4, Pages (October 2008)
Volume 140, Issue 1, Pages (January 2011)
Volume 142, Issue 2, Pages (February 2012)
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 154, Issue 4, Pages (March 2018)
Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,
Volume 140, Issue 5, Pages (May 2011)
Volume 151, Issue 5, Pages e4 (November 2016)
Volume 135, Issue 1, Pages (July 2008)
Volume 155, Issue 5, Pages e2 (November 2018)
Volume 132, Issue 4, Pages (April 2007)
Volume 146, Issue 1, Pages e35 (January 2014)
Volume 142, Issue 7, Pages e3 (June 2012)
Volume 132, Issue 7, Pages (June 2007)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 126, Issue 5, Pages (May 2004)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 137, Issue 1, Pages (July 2009)
Volume 140, Issue 4, Pages (April 2011)
Volume 39, Issue 5, Pages (November 2003)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 142, Issue 7, Pages e2 (June 2012)
Volume 123, Issue 4, Pages (October 2002)
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 135, Issue 2, Pages (August 2008)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 145, Issue 3, Pages e11 (September 2013)
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 130, Issue 7, Pages (June 2006)
Volume 134, Issue 1, Pages (January 2008)
Volume 133, Issue 4, Pages (October 2007)
Volume 135, Issue 4, Pages (October 2008)
Volume 138, Issue 3, Pages e3 (March 2010)
Volume 127, Issue 3, Pages (September 2004)
Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis  Jin Dong Kim, Jong Young Choi, Si Hyun.
Volume 140, Issue 7, Pages e2 (June 2011)
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Volume 135, Issue 4, Pages (October 2008)
Volume 128, Issue 3, Pages (March 2005)
Volume 132, Issue 2, Pages (February 2007)
Volume 20, Issue 3, Pages (March 2012)
Volume 22, Issue 2, Pages (February 2014)
Presentation transcript:

Volume 136, Issue 2, Pages 652-662.e3 (February 2009) Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes  Masaya Sugiyama, Yasuhito Tanaka, Fuat Kurbanov, Isao Maruyama, Takashi Shimada, Satoru Takahashi, Tomoyuki Shirai, Keisuke Hino, Isao Sakaida, Masashi Mizokami  Gastroenterology  Volume 136, Issue 2, Pages 652-662.e3 (February 2009) DOI: 10.1053/j.gastro.2008.10.048 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Comparative dynamic profile of HBV-DNA and antigen levels in sera of mice inoculated with preinfected-mice sera recovered from culture media transfecting HBV construct. (A) Levels of HBV DNA in sera of the chimeric mice inoculated with HBV/A2, C2, B1_wild, or B1_PCm. Shaded in gray is an area below the detection limit (<103 copies/mL) of the real-time detection PCR assay. *Statistical differences with a P value of less than .05. **Statistical differences with a P value of less than .01. (B) Dynamic profiles of HBV antigen expression, as revealed by quantification of HBsAg, HBeAg, and HBcrAg in sera of the chimeric mice (see Supplementary Materials and Methods section). For each group, mean values observed in 9–11 chimeric mice are depicted with the standard deviation bars. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Comparative dynamic profile of HBV-DNA antigen levels in sera of mice inoculated with patient sera from HBV/B1_wild (PC wild-type) and HBV/B1_PCm (PC mutant). (A) Mice inoculated with sera from HBV/B1_wild–infected carriers developed acute hepatitis B or from HBV/B1_PCm-infected carriers developed fulminant hepatitis B and were assessed for levels of HBV DNA in mice sera with real-time detection PCR weekly. The area below the detection limit (<103 copies/mL) is shaded in gray. (B) Dynamic profiles of HBV antigens including HBsAg and HBcrAg in mice corresponding to panel A. For each genotype, mean values observed in 9–11 chimeric mice are depicted with the standard deviation bars. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Immunohistochemical analysis of liver tissue. Comparison of liver histology in mice long-term (25 weeks) infected with HBV/A2, C2, B1_wild, B1_PCm, and noninfected control. Liver sections stained with H&E, MT, or orcein are shown. After deparaffinization, tissue slides were stained according to each method. Representative staining of C2 and B1_PCm showed a ground-glass appearance, fibrosis, and cytoplasmic positivity of human hepatocytes by orcein staining (brown), whereas these were absent in A2, B1_wild, and control mice. Original magnifications: H&E and orcein, 200×; MT, 100×. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Confirmation of liver fibrosis by immunostaining using anti–α-SMA antibody. (A) Liver sections stained with H&E, MT, or immunostaining using anti–α-SMA antibody (as described in the Materials and Methods section). (B) Nuclei stained brown with the antibodies indicate human origin, and α-SMA is stained in red, located in the cytoplasm without a stained nucleus. Shown are representative staining of images expressing fibrosis. Original magnification, 200×. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Differences in production of oxidative damage among HBV genotypes. (A) Frozen liver sections of mice inoculated with different HBV genotypes were stained by dihydroethidium. Fluorescence was detected with a laser scanning microscope. (B) Fluorescence intensities in randomly selected areas of digital images were quantified by National Institutes of Health image analysis software. *P < .01: A2 or B1_wild vs C2 or B1_PCm. (C) Oxidative damages in liver tissue were evaluated by staining of 8-OHdG–positive nuclei. Original magnifications, 200×. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Differences in the expression levels of fibrosis-related genes among HBV genotypes. Quantification of (A) ALT and (B) TGF-β1 levels in mouse sera with enzyme-linked immunosorbent assay (see Supplementary Materials and Methods section. non-F, no fibrosis group (A2 and B1_wild); F, fibrosis group (C2 and B1_PCm). *P < .01: non-F vs F. (C) The specificity of each PCR using species-specific primer sets. The species-specific primer sets were established to determine whether mRNA of fibrosis-related genes were of human or mouse origin. Liver tissue of a HCC patient or a mouse without transplantation of human hepatocytes was used to check the primer sets for real-time detection PCR. The PCR products were run on 2% agarose gels to confirm the molecular sizes as well as species-specific amplifications. (D) Quantification of mRNA expression on fibrosis-related genes in each group by real-time reverse-transcription PCR. non-F group, n = 15; F group, n = 22; control, n = 8; ND, not detected; *P < .001. Gastroenterology 2009 136, 652-662.e3DOI: (10.1053/j.gastro.2008.10.048) Copyright © 2009 AGA Institute Terms and Conditions